Management of refractory trophoblastic neoplasia.

SU Hao, FENG Feng-zhi

Chinese Journal of Practical Gynecology and Obstetrics ›› 2022, Vol. 38 ›› Issue (5) : 511-514.

Chinese Journal of Practical Gynecology and Obstetrics ›› 2022, Vol. 38 ›› Issue (5) : 511-514. DOI: 10.19538/j.fk2022050109

Management of refractory trophoblastic neoplasia.

Author information +
History +

Abstract

All patients with refractory gestational trophoblastic neoplasia (GTN) require re-assessment of the extent of disease before initiating another treatment. Salvage chemotherapy with multiagent combination is still the main treatment option at present. For the patients with resectable lesions,it is crucial to perform a complete surgical excision of tumors simultaneously during salvage chemotherapy. In addition,these patients may also benefit from the emerging immunotherapy. After remission is achieved,serum human chorionic gonadotrophin (hCG) should be monitored regularly in a long term.

Key words

gestational trophoblastic neoplasia / refractory / chemotherapy / surgery / immunotherapy

Cite this article

Download Citations
SU Hao, FENG Feng-zhi. Management of refractory trophoblastic neoplasia.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2022, 38(5): 511-514 https://doi.org/10.19538/j.fk2022050109

Accesses

Citation

Detail

Sections
Recommended

/